These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27639091)

  • 1. Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
    Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27639091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
    Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged clonazepam-induced withdrawal symptoms in an NAT2 ultraslow acetylator.
    Ho TT; Gupta SV; Sanchez-Valle A
    Pharmacogenomics; 2019 Jan; 20(2):69-73. PubMed ID: 30520338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia.
    Menus Á; Kiss Á; Tóth K; Sirok D; Déri M; Fekete F; Csukly G; Monostory K
    Sci Rep; 2020 Dec; 10(1):21283. PubMed ID: 33277605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
    Kiss Á; Menus Á; Tóth K; Déri M; Sirok D; Gabri E; Belic A; Csukly G; Bitter I; Monostory K
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):71-82. PubMed ID: 30604050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
    Zastrozhin MS; Skryabin VY; Smirnov VV; Petukhov AE; Pankratenko EP; Zastrozhina AK; Grishina EA; Ryzhikova KA; Bure IV; Golovinskii PA; Koporov SG; Bryun EA; Sychev DA
    Gene; 2020 May; 739():144513. PubMed ID: 32112986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients.
    Deininger KM; Vu A; Page RL; Ambardekar AV; Lindenfeld J; Aquilante CL
    Clin Transplant; 2016 Sep; 30(9):1074-81. PubMed ID: 27314545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepam.
    Olivera M; Martínez C; Gervasini G; Carrillo JA; Ramos S; Benítez J; García-Martin E; Agúndez JA
    Drug Metab Lett; 2007 Jan; 1(1):3-5. PubMed ID: 19356010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-Guided Hydralazine Therapy.
    Collins KS; Raviele ALJ; Elchynski AL; Woodcock AM; Zhao Y; Cooper-DeHoff RM; Eadon MT
    Am J Nephrol; 2020; 51(10):764-776. PubMed ID: 32927458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
    Du J; Zhang A; Wang L; Xuan J; Yu L; Che R; Li X; Gu N; Lin Z; Feng G; Xing Q; He L
    J Psychopharmacol; 2010 Jul; 24(7):1115-20. PubMed ID: 19395426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of enzymes responsible for nitrazepam metabolism and toxicity in human.
    Konishi K; Fukami T; Gotoh S; Nakajima M
    Biochem Pharmacol; 2017 Sep; 140():150-160. PubMed ID: 28606603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive clonazepam in the treatment of chronic schizophrenia.
    Herrera JM; Alvarez WA; Freinhar JP; Lawson WB; Sramek JJ
    Int J Psychosom; 1991; 38(1-4):17-20. PubMed ID: 1685726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients.
    Bonnet S; Falkowski S; Deppenweiler M; Monchaud C; Arnion H; Picard N; Woillard JB
    Pharmacogenomics J; 2020 Oct; 20(5):647-654. PubMed ID: 32015456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment.
    Shilbayeh SA; Sy SK; Melhem M; Zmeili R; Derendorf H
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):387-94. PubMed ID: 27137148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism.
    Sanchez Spitman AB; Moes DJAR; Gelderblom H; Dezentje VO; Swen JJ; Guchelaar HJ
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1589-1598. PubMed ID: 28849250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of pharmacogenomic very important pharmacogenomic variants:
    Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B
    Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.
    Willrich MA; Rodrigues AC; Cerda A; Genvigir FD; Arazi SS; Dorea EL; Bernik MM; Bertolami MC; Faludi A; Largura A; Baudhuin LM; Bryant SC; Hirata MH; Hirata RD
    Clin Chim Acta; 2013 Jun; 421():157-63. PubMed ID: 23501331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
    Bendaly J; Zhao S; Neale JR; Metry KJ; Doll MA; States JC; Pierce WM; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1503-9. PubMed ID: 17627018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.